Beispiel: Heart Attack

Suchen Sie in klinischen Studien nach: Imipenem

Insgesamt 87 ergebnisse

NCT03776305

Unbekannter Status

Imipenem in Critically Ill Patients

Bedingungen: Critically Ill Patients With ECMO
NCT02897206

Abgeschlossen

Imipenem Prophylaxis in Patients With Acute Pancreatitis

Bedingungen: Acute Pancreatitis
NCT03308214

Abgeschlossen

The Analysis of Factors Influencing the Vd of Imipenem in Septic Shock Patients

Bedingungen: Septic Shock
NCT04147221

Rekrutierung

Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance

Bedingungen: Sepsis
NCT00950222

Abgeschlossen

Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic

Bedingungen: Ventilator Associated Pneumonia
NCT02616354

Unbekannter Status

Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin

Bedingungen: Sepsis
NCT01489124

Abgeschlossen

The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia

Bedingungen: Ventilator-Associated Pneumonia
NCT04493151

Rekrutierung

Imipenem/Cilastatin/Relebactam PK in ECMO

Bedingungen: Sepsis
NCT04802863

Noch nicht rekrutiert

Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects

Bedingungen: Bacterial Infections
NCT03293485

Abgeschlossen

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Bedingungen: Complicated Intra-abdominal Infection; Complicated Urinary Tract Infection
NCT02213783

Abgeschlossen

Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia

Bedingungen: Patients With Febrile Neutropenia
NCT03733340

Unbekannter Status

Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT

Bedingungen: Antibacterial Prophylaxis; Hematological Malignancies; Allogenetic Hematopoietic Stem Cell Transplantation; Imipenem
NCT01379157

Abgeschlossen

Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia

Bedingungen: Ventilator Associated Pneumonia
NCT03858387

Rekrutierung

PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients

Bedingungen: Critical Illness; Bacterial Infections
NCT01852630

Abgeschlossen

Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure

Bedingungen: Spontaneous Bacterial Peritonitis
NCT02321800

Abgeschlossen

A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections

Bedingungen: Urinary Tract Infections
NCT03177720

Rekrutierung

Evaluation of Innovative Tools in Development of Antibiotics

Bedingungen: Pneumonia
NCT00589693

Beendet

To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia

Bedingungen: Ventilator-Associated Pneumonia
NCT04785924

Noch nicht rekrutiert

Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections

Bedingungen: Carbapenem-Resistant Enterobacteriaceae Infection; KPC; Gram-Negative Bacterial Infections; Antibiotic Resistant Infection
NCT02474706

Beendet

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli

Bedingungen: Urinary Tract Infections
NCT02149329

Abgeschlossen

Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO

Bedingungen: Febrile Neutropenia; Hematological Malignancy
NCT02452047

Abgeschlossen

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)

Bedingungen: Bacterial Infections
NCT00871104

Abgeschlossen

Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis

Bedingungen: Infective Endocarditis
NCT01505634

Abgeschlossen

Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003)

Bedingungen: Urinary Tract Infections; Pyelonephritis
NCT04208763

Rekrutierung

A Randomized Controlled Trial Comparing Imipenem and Tigecycline Versus Imipenem and Tigecycline With GM-CSF for the Management of Spontaneous Bacterial Peritonitis Presenting With Septic Shock.

Bedingungen: Spontaneous Bacterial Peritonitis